What is the Current Share Price of Par Drugs & Chemicals Ltd?
- Answer Field
-
Par Drugs & Chemicals Ltd share price is for NSE ₹ 92.38 & for BSE ₹ 0.00 as on Dec 12 2025 03:29 PM.
As of the latest trading session, PAR DRUGS AND CHEM LTD share price is currently at ₹ 92.38, which is down by ₹ -1.82 from its previous closing. Today, the stock has fluctuated between ₹ 91.06 and ₹ 95.09. Over the past year, PAR DRUGS AND CHEM LTD has achieved a return of -58.99 %. In the last month alone, the return has been -5.72 %. Read More...
| Particulars | SEP 2025 (Values in Cr) |
|---|---|
| Revenue | 28.66 |
| Operating Expense | 23.58 |
| Net Profit | 4.13 |
| Net Profit Margin (%) | 14.41 |
| Earnings Per Share (EPS) | 3.36 |
| EBITDA | 6.53 |
| Effective Tax Rate (%) | 25.58 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.97 | 14.20 | 1.50 | 222.01 | 25.97 / 67.90 |
| BLISS GVS PHARMA LTD | 144.15 | 13.91 | 1.34 | 1524.95 | 105.05 / 190.65 |
| CIPLA LTD | 1517.20 | 22.52 | 3.72 | 122555.05 | 1310.05 / 1672.20 |
| FERMENTA BIOTECH LIMITED | 340.35 | 8.94 | 2.56 | 1001.68 | 219.00 / 449.00 |
| GLAXOSMITHKLINE PHARMA LT | 2598.00 | 46.17 | 25.77 | 44011.69 | 1924.30 / 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.97 | 23.55 | 4.03 | 222.01 | 25.97 / 67.90 |
| AMRUTAJAN HEALTH LTD | 689.65 | 35.17 | 5.82 | 1993.82 | 548.05 / 829.00 |
| ASTRAZENECA PHARMA IND LT | 9138.35 | 98.83 | 28.59 | 22845.88 | 6301.00 / 10653.05 |
| BLISS GVS PHARMA LTD | 144.15 | 19.45 | 1.38 | 1524.95 | 105.05 / 190.65 |
Choose a Plan That Suits Your Goals and Needs
Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018.
The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani. The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business. With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets.
At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx. 9,700 MTPA. Block 1- APIs, Block 2- Magnesium Hydroxide, Block 3- Fine Chemicals and Block 4- APIs/ Fine Chemicals. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.
The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.
The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019.
In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.
Par Drugs & Chemicals Ltd share price is for NSE ₹ 92.38 & for BSE ₹ 0.00 as on Dec 12 2025 03:29 PM.
The market cap of Par Drugs & Chemicals Ltd for NSE ₹ 113.30 & for BSE ₹ 0.00 as on Dec 12 2025 03:29 PM.
The 52 Week High and Low of Par Drugs & Chemicals Ltd for NSE is ₹ 230.05 and ₹ 81.01 and for BSE is ₹ 0.00 and ₹ 0.00.
The 1 year returns on the stock has been -58.99%.
As on Dec 12 2025 03:29 PM the price-to-earnings (PE) ratio for Par Drugs & Chemicals Ltd share is 11.70.
As on Dec 12 2025 03:29 PM, the price-to-book (PB) ratio for Par Drugs & Chemicals Ltd share is 86.49.
You can trade in Par Drugs & Chemicals Ltd shares with Bajaj Broking by opening a demat account.
To buy Par Drugs & Chemicals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Par Drugs & Chemicals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found